552 related articles for article (PubMed ID: 14565855)
1. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
[TBL] [Abstract][Full Text] [Related]
3. Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats.
Roulot D; Sevcsik AM; Coste T; Strosberg AD; Marullo S
Hepatology; 1999 Jun; 29(6):1730-8. PubMed ID: 10347115
[TBL] [Abstract][Full Text] [Related]
4. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
5. The role of TGF-beta 1 and cytokines in the modulation of liver fibrosis by Sho-saiko-to in rat's bile duct ligated model.
Chen MH; Chen JC; Tsai CC; Wang WC; Chang DC; Tu DG; Hsieh HY
J Ethnopharmacol; 2005 Feb; 97(1):7-13. PubMed ID: 15652268
[TBL] [Abstract][Full Text] [Related]
6. [Effects of antisense transforming growth factor beta receptor-II (TGFbetaRII) expressing plasmid on experimental liver fibrosis].
Jiang W; Wang JY; Yang CQ; Liu WB; Wang YQ; He BM
Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):137-40. PubMed ID: 15059294
[TBL] [Abstract][Full Text] [Related]
7. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
Chen A
Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
[TBL] [Abstract][Full Text] [Related]
8. Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation.
Osawa Y; Seki E; Adachi M; Taura K; Kodama Y; Siegmund SV; Schwabe RF; Brenner DA
Liver Int; 2006 Nov; 26(9):1138-47. PubMed ID: 17032415
[TBL] [Abstract][Full Text] [Related]
9. Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis.
Yang L; Chan CC; Kwon OS; Liu S; McGhee J; Stimpson SA; Chen LZ; Harrington WW; Symonds WT; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G902-11. PubMed ID: 16798724
[TBL] [Abstract][Full Text] [Related]
10. Prevention of CCl4-induced liver cirrhosis by ribbon antisense to transforming growth factor-beta1.
Doh KO; Jung HK; Moon IJ; Kang HG; Park JH; Park JG
Int J Mol Med; 2008 Jan; 21(1):33-9. PubMed ID: 18097613
[TBL] [Abstract][Full Text] [Related]
11. Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells.
Wiercinska E; Wickert L; Denecke B; Said HM; Hamzavi J; Gressner AM; Thorikay M; ten Dijke P; Mertens PR; Breitkopf K; Dooley S
Hepatology; 2006 May; 43(5):1032-41. PubMed ID: 16628634
[TBL] [Abstract][Full Text] [Related]
12. Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis.
Ryu SH; Chung YH; Lee JK; Kim JA; Shin JW; Jang MK; Park NH; Lee HC; Lee YS; Suh DJ
Liver Int; 2009 Feb; 29(2):308-14. PubMed ID: 18564211
[TBL] [Abstract][Full Text] [Related]
13. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
Hsu YC; Chiu YT; Cheng CC; Wu CF; Lin YL; Huang YT
J Gastroenterol Hepatol; 2007 Jan; 22(1):99-111. PubMed ID: 17201889
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis.
Uchio K; Graham M; Dean NM; Rosenbaum J; Desmoulière A
Wound Repair Regen; 2004; 12(1):60-6. PubMed ID: 14974966
[TBL] [Abstract][Full Text] [Related]
15. Expression of extracellular matrix genes in cultured hepatic oval cells: an origin of hepatic stellate cells through transforming growth factor beta?
Wang P; Liu T; Cong M; Wu X; Bai Y; Yin C; An W; Wang B; Jia J; You H
Liver Int; 2009 Apr; 29(4):575-84. PubMed ID: 19323784
[TBL] [Abstract][Full Text] [Related]
16. Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis.
Borkham-Kamphorst E; Stoll D; Gressner AM; Weiskirchen R
Biochem Biophys Res Commun; 2004 Aug; 321(2):413-23. PubMed ID: 15358192
[TBL] [Abstract][Full Text] [Related]
17. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis.
Ueberham E; Löw R; Ueberham U; Schönig K; Bujard H; Gebhardt R
Hepatology; 2003 May; 37(5):1067-78. PubMed ID: 12717387
[TBL] [Abstract][Full Text] [Related]
18. Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis.
Okada H; Kikuta T; Kobayashi T; Inoue T; Kanno Y; Takigawa M; Sugaya T; Kopp JB; Suzuki H
J Am Soc Nephrol; 2005 Jan; 16(1):133-43. PubMed ID: 15574513
[TBL] [Abstract][Full Text] [Related]
19. The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells.
Herrmann J; Borkham-Kamphorst E; Haas U; Van de Leur E; Fraga MF; Esteller M; Gressner AM; Weiskirchen R
Biochem Biophys Res Commun; 2006 Jul; 345(4):1526-35. PubMed ID: 16735029
[TBL] [Abstract][Full Text] [Related]
20. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats.
Yasuda H; Imai E; Shiota A; Fujise N; Morinaga T; Higashio K
Hepatology; 1996 Sep; 24(3):636-42. PubMed ID: 8781336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
